<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>75(6)</volume><submitter>Pai UM</submitter><pubmed_abstract>The objective of the study was to find the prevalence of metabolic syndrome along with identifying the atrial arrhythmias, QT&lt;sub>C&lt;/sub> interval, and coronary artery disease among these patients during follow-ups. Among 171 subjects who were implanted with permanent pacemakers, metabolic syndrome was present in 90 (52.6 %). Prevalence of Arrhythmias was 49 (28.7 %), atrial tachycardia (AT)/atrial fibrillation (AF) was seen in 29 (17 %) patients. Our study showed that there is a strong association between metabolic syndrome and atrial arrhythmias. Metabolic syndrome, age, coronary artery disease and Systolic blood pressure were good independent predictors of atrial arrhythmias among patients with pacemaker implantation.</pubmed_abstract><journal>Indian heart journal</journal><pagination>462-464</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10774609</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality.</pubmed_title><pmcid>PMC10774609</pmcid><pubmed_authors>Prabhu S</pubmed_authors><pubmed_authors>Rao DS</pubmed_authors><pubmed_authors>V C</pubmed_authors><pubmed_authors>V R</pubmed_authors><pubmed_authors>Samanth J</pubmed_authors><pubmed_authors>Pai UM</pubmed_authors><pubmed_authors>Prabhu MA</pubmed_authors><pubmed_authors>Devasia DT</pubmed_authors><pubmed_authors>Mathias HL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality.</name><description>The objective of the study was to find the prevalence of metabolic syndrome along with identifying the atrial arrhythmias, QT&lt;sub>C&lt;/sub> interval, and coronary artery disease among these patients during follow-ups. Among 171 subjects who were implanted with permanent pacemakers, metabolic syndrome was present in 90 (52.6 %). Prevalence of Arrhythmias was 49 (28.7 %), atrial tachycardia (AT)/atrial fibrillation (AF) was seen in 29 (17 %) patients. Our study showed that there is a strong association between metabolic syndrome and atrial arrhythmias. Metabolic syndrome, age, coronary artery disease and Systolic blood pressure were good independent predictors of atrial arrhythmias among patients with pacemaker implantation.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov-Dec</publication><modification>2025-04-22T18:12:12.667Z</modification><creation>2025-04-06T02:21:08.159Z</creation></dates><accession>S-EPMC10774609</accession><cross_references><pubmed>37918562</pubmed><doi>10.1016/j.ihj.2023.10.006</doi></cross_references></HashMap>